Previous Article | Next Article 
Infection and Immunity, November 2000, p. 6273-6280, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Genetic Dissection of Primary and Secondary
Responses to a Widespread Natural Pathogen of the Gut,
Eimeria vermiformis
Adrian L.
Smith1,2 and
Adrian C.
Hayday1,3,*
Department of Molecular Cell and
Developmental Biology, Yale University, New Haven,
Connecticut,1 and Institute for
Animal Health, Compton, Berkshire,2 and
Department of Immunobiology, GKT School of Medicine,
University of London, London,3 United Kingdom
Received 12 June 2000/Returned for modification 22 July
2000/Accepted 3 August 2000
 |
ABSTRACT |
Because most pathogens initially challenge the body at epithelial
surfaces, it is important to dissect the mechanisms that underlie
T-cell responses to infected epithelial cells in vivo. The coccidian
parasites of the genus Eimeria are protozoan gut pathogens
that elicit a potent, protective immune response in a wide range of
host species. CD4+ 
T cells and gamma interferon (IFN-
) are
centrally implicated in the primary immunoprotective response. To
define any additional requirements for the primary response and to
develop a comparison between the primary and the secondary response, we
have studied Eimeria infections of a broad range of
genetically altered mice. We find that a full-strength primary response
depends on
2-microglobulin (class I major
histocompatibility complex [MHC] and class II MHC and on IFN-
and
interleukin-6 (IL-6) but not on TAP1, perforin, IL-4, Fas ligand, or
inducible nitric oxide synthetase. Indeed, MHC class II-deficient and
IFN-
-deficient mice are as susceptible to primary infection as mice
deficient in all 
T cells. Strikingly, the requirements for a
highly effective 
-T-cell-driven memory response are less
stringent, requiring neither IFN-
nor IL-6 nor class I MHC. The
class II MHC dependence was also reduced, with adoptively transferable
immunity developing in MHC class II
/
mice. Besides the
improved depiction of an immune response to a natural gut pathogen, the
finding that effective memory can be elicited in the absence of primary
effector responses appears to create latitude in the design of vaccine strategies.
 |
INTRODUCTION |
A primary goal of immunological
research is to understand how protective primary and secondary immune
responses against natural infectious pathogens are mounted. This
understanding will aid in the management of infectious disease and the
design of vaccines that elicit effective secondary responses. To this
end, recent research has developed operational paradigms for immune
responses to different pathogens. For example, the linkage of disease
resistance to the effective operation of either T-helper-cell type 1 (Th1) or T-helper-cell type 2 (Th2) responses during challenge with pathogens such as Leishmania major, Listeria monocytogenes,
Toxoplasma gondii, and various nematodes (1,4,8,24).
Commonly, pathogens make primary contact with the host via infection of
an external body surface, particularly the intestinal epithelium. Thus,
the immune responses active at body surfaces are an essential component
of the host-pathogen relationship. Consistent with this, the intestine
displays a complex gut-associated lymphoid tissue (GALT), with
lymphocytes present in mesenteric lymph nodes, specialized follicles
such as Peyer's patches, the lamina propria, and the epithelium
itself. At the same time, the gut immune system must remain tolerant to
innocuous foreign antigens such as those ingested as food. Thus,
effective understanding of GALT has the potential both to aid oral
vaccination programs for infectious diseases and to guide oral
tolerance strategies to ameliorate autoimmunity (55).
Nonetheless, there are few instances in which the primary and secondary
immune responses to natural and widespread infectious pathogens of the
gut epithelium have been defined in detail. This is in part because
many studies have focused on pathogens delivered experimentally via
subcutaneous, intravenous, and/or intraperitoneal injection. Such
studies cannot assess whether immune responses to infected epithelia
adhere strictly to general rules established for systemic responses or
whether there are site-specific immune effector mechanisms. Significant
questions include the degree to which Th1 and Th2 dichotomies and
nonconventional antigen presentation mechanisms might be involved in
intestinal responses and the differences in the respective requirements
for mounting primary and secondary responses. By the direct study of a
natural, widespread infection of the gut epithelium, this paper
provides answers to these questions.
The epithelium-tropic protozoan Eimeria vermiformis is an
example of an organism causing a natural intestinal infection to which
vertebrates mount a highly effective immune response.
Eimeria spp. are apicomplexans closely related to human
pathogens Cryptosporidium spp., T. gondii, and
Sarcocystis spp., all of which reside in or enter the body
via the intestinal epithelium (10). Additionally, eimerian
parasites have an inherent biological significance: there are estimated
to be over 10,000 species that together target most vertebrates prior
to and throughout breeding age. Hence, Eimeria may have
provided a significant evolutionary pressure for the development of
effective intestinal immune responses. Currently, significant economic
cost is caused by infection of livestock with different
Eimeria spp., leading to a clinical condition known as
intestinal coccidiosis (47).
Infection by E. vermiformis is largely limited to the
intestinal epithelium and can be initiated via the natural route by intubation of the esophagus. The resistance or susceptibility of an
animal to primary infection can be reliably quantified by enumeration
of parasites released into the feces and by the length of the "patent
period" over which this occurs (36, 39). Previous studies
have clearly established that 
-T-cell immunity is central to the
effective attenuation of primary infection (reviewed in reference
35; 54). Moreover, the immune response to E. vermiformis is highly effective, and within a 2- to 3-week period
all conventional inbred mouse strains develop essentially complete
immunity to reinfection by an inoculum 1,000 times greater than the
primary challenge (39; A. L. Smith and A. C. Hayday, unpublished observations). We previously showed
that 
T cells are likewise necessary for the memory response and
that the resistance to neither primary nor secondary infection is
affected by the congenital absence of 
cells (33).
These results are consistent with the findings that

-T-cell-deficient mice are defective in specific T-cell-mediated immunity to the majority of (possibly all) pathogens so far employed (14, 22, 26, 52).
Although the host response attenuates primary infection,
Eimeria spp. are intrinsically self-limiting. Hence, within
3 to 4 weeks even highly immunocompromised hosts become completely cleared of the pathogen (33, 36). Experimentally, this is a
useful property, because although it limits the quantitative difference
in susceptibility between fully immunocompetent and fully
immunocompromised mice (e.g., SCID mice), the complete clearance of the
primary infection allows unequivocal evaluation of the secondary
response in variably immunocompromised animals. This contrasts with
other popular models of infection, where attenuated pathogens or
uncertain drug treatment strategies are required to eliminate the
primary inoculum from immunodeficient animals. This property was
exploited in this study to allow an improved understanding of
respective mechanisms of the 
-T-cell-mediated primary and
secondary responses. To date, antibody depletion and adoptive-transfer
experiments have indicated that CD4+ T cells and gamma interferon
(IFN-
) are involved in the development of the primary response,
suggesting that it may conform to the Th1 paradigm (37, 38, 40,
41). Nonetheless, a detailed genetic analysis of the primary
response had yet to be undertaken. Likewise, the requirements for the
secondary response over and above an essential role for 
T cells
had heretofore remained opaque.
 |
MATERIALS AND METHODS |
Animals.
I-A
/
, T-cell
receptor-
/
(TCR
/
, and TCR
(
×
) mice were crossed onto a C57BL/6 background (10 generations) and bred and maintained at Yale University in
specific-pathogen-free isolators in an accredited facility. C57BL/6,
F2(129 × C57BL/6),
2-microglobulin
/
(
2m
/
) (both C57BL/6 and mixed
backgrounds), TAP1
/
(mixed background),
IFN-
/
(C57BL/6 background),
interleukin-4
/
(IL-4
/
) (C57BL/6
background), IL-6
/
(mixed background bred back an
unknown number of times to C57BL/6), perforin
/
(C57BL/6
background), and some TCR
/
(C57BL/6 background) mice
were originally purchased from Jackson Laboratory (Bar Harbor, Maine).
Mice were given an invariant diet (Hamster chow 3500) and water ad
libitum. Animals were 6 to 10 weeks of age for primary infection, and
secondary infections were initiated 4 to 6 weeks after primary infection.
Parasites and oocyst enumeration.
E. vermiformis
(kind gift from K. S. Todd, University of Illinois) was maintained
by passage in vivo, with oocysts purified and sporulated as described
previously (39). Sporulation was scored microscopically, and
mice were given 102 or 103 sporulated oocysts
in 100 µl of water by oral gavage. At the beginning of patency (7 days postinfection), mice were individually caged and maintained
over autoclaved sand, preventing reingestion of fecal material. All
fetal material was collected at 24-h periods until no oocysts could be
detected. Total oocysts in each collected fecal sample were counted
after salt flotation in McMaster chambers, and the susceptibility for
each infection was described by the total oocyst counts over the patent
period. It was not appropriate to correct oocyst yields to the weight
in grams of fecal material, because fecal consistency inevitably
changed across the course of the infection. Because the
Eimeria stocks were prepared by passage in vivo, the potency
inevitably varied among inocula. For this reason, all experiments were
strictly internally controlled.
Preparation of lymphocytes.
Spleens and mesenteric lymph
nodes were removed from freshly euthanized mice using a sterile
technique, and lymphocyte suspensions were prepared by gently
disrupting diced organs through a steel mesh into sterile
phosphate-buffered saline (PBS; pH 7.2)-2% fetal calf serum and
maintained on ice. Erythrocytes were removed from spleen preparations
by "flash lysis" according to a standard technique (56).
Small intestine intraepithelial lymphocytes were prepared as described
previously (17). Lymphocytes were washed, resuspended, and
counted microscopically; viability always exceeded 90% according to
trypan blue exclusion.
Adoptive transfer.
For adoptive transfer, cells were
resuspended in PBS, pH 7.2, and injected intraperitoneally into
recipient mice. Controls received PBS, pH 7.2, with no cells. Recipient
mice were challenged with E. vermiformis 24 h after
adoptive transfer, as described by Rose et al. (38, 42).
 |
RESULTS |

T cells are essential for immunity to primary and secondary
infection by E. vermiformis.
Data shown in Fig.
1 demonstrate that
TCR
/
mice are highly susceptible to primary
infection and remain highly susceptible to subsequent infection whereas
intact mice are completely immune to reinfection. This supports an
earlier report in which TCR
/
mice were used
(33) and in which 
-cell-deficient mice were shown to
have no overt susceptibility to either primary or secondary infection.
Collectively, these data provide the basis for examining the antigen
presentation and effector requirements for 
T cells that are
relevant to the anticoccidial response.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
TCR / mice are highly susceptible to
primary infection with E. vermiformis and do not
develop immune memory to reinfection. C57BL/6 and C57BL/6
TCR / mice were infected with 1,000 sporulated
oocysts of E. vermiformis, and secondary infection was
initiated 30 days after primary infection. Results of oocyst counts and
patent periods are means ± standard errors from groups of 6 to 10 individually housed animals. *, significant difference between
experimental groups infected at the same time (P < 0.05).
|
|
Antigen presentation pathways involved in the primary response to
Eimeria.
Previous studies have shown that mice depleted of
CD4+ cells by administration of L3T4 antibody in vivo are
highly sensitive to primary infection by E. vermiformis
(37, 38). Likewise, protection conferred on naive mice by
adoptive transfer of mesenteric lymph node T cells from infected mice
was abrogated by depletion of CD4+ T cells from the
inoculum (38). Conversely, anti-CD8 antibodies had no effect
(38). To investigate the pathway(s) of antigen presentation
to which active CD4+ cells are restricted, a series of
infections was carried out in mice deficient in major
histocompatibility complex (MHC) functions (Table
1). C57BL/6 I-A
/
mice are
deficient in class II MHC because the targeted disruption of I-A
is
set against a mutation in I-E; there are very few CD4+
cells in these mice (7, 19).
2m
/
mice are severely deficient in the
expression of most conventional class I MHC molecules and
nonconventional class Ib MHC molecules; there are very few
CD8+ cells in these mice (5, 59). Likewise,
TAP1
/
mice harbor reduced numbers of CD8+
MHC class I-restricted cells, because they cannot stabilize
conventional, peptide-dependent MHC class I molecules (53).
However, there are greater numbers of class I and class Ib MHC-reactive
cells in TAP1
/
mice than in
2m
/
mice because there is scope in
TAP1
/
mice for the stabilization of some conventional
class I molecules by TAP-independent leader peptides and for the
expression of MHC class Ib molecules, such as CD1 and TL, that are
2m dependent and TAP1 independent (6).
Data derived from five independent experiments are shown in Table
1.
Because
Eimeria stocks are prepared by passage in vivo,
their potency inevitably varies among inocula and with storage
over
time (compare data for C57BL/6 mice in different experiments
in Table
1). Although this makes it difficult to use the same
inocula to infect
a wide range of different hosts, all experiments
are tightly internally
controlled (e.g., relative to C57BL/6 mice),
and all comparisons are
made within rather than across experimental
groups. Some clear
conclusions can be drawn. First, experiments
1 and 2 demonstrate that
I-A
/
mice are ~10-fold more susceptible than congenic
C57BL/6 mice
and have susceptibility similar to that of
TCR

/
mice (experiment 2, Table
1). Compared to a
normal yield of
~10 million oocysts shed over a patent period of ~8
days, I-A
/
mice yield ~100 million parasites over
~14 days. (The results
of secondary infection, also shown in Table
1,
will be considered
below.)
Experiment 5 demonstrates that
F
2(129 × C57BL/6)TAP1
/
and
F
2(129 × C57BL/6)TAP1
+/+ mice are
essentially indistinguishable from one another in oocyst
yield and in
patent period. This insensitivity to TAP1 deficiency
is consistent with
previous data that depletion of CD8
+ cells does not
compromise the immune response (
37). However,
TAP1
/
mice are more resistant than
F
2(129 × C57BL/6)
2m
/
mice. Experiments 3 and 4 confirm the increased susceptibility
to
primary infection of inbred C57BL/6
2m
/
mice compared to that of congenic C57BL/6
2m
+/
or
2m
+/+
mice. The sensitivity to
2m deficiency but not to TAP1
deficiency
suggests a role for cells regulated either by a
nonconventional
MHC class I pathway of antigen presentation (e.g.,
TAP-independent
loading of leader peptides) or by TAP-independent,
2m-dependent
MHC class I-related molecules, e.g., TL and
CD1. Given that CD8
depletion, albeit by antibody treatment rather than
null mutation,
was previously shown to have no effect on the primary
response
(
37), it is possible that the cells in question are
either CD4
+ CD8

or CD4

CD8

(double-negative) cells (see Discussion). Likewise,
because the
primary response is insensitive to


-cell deficiency
(
33),
the
2m dependence is not likely to be a
manifestation of


-cell
involvement.
Effector molecules involved in the primary response to
Eimeria.
The effector mechanism utilized by the MHC class
II-restricted response was analyzed in mice deficient in a range of
molecules. These included mice deficient in cytokines (Table
2) IFN-
(since it is the defining Th1
cytokine [27]), IL-4 (since it is a defining Th2
cytokine [27]), IL-6 (since IL-6 has been reported to
have effects on priming Th2 responses [32] and on Th1
and neutrophil responses [12, 34, 43]) and mice
deficient in cytotoxic activities (Table
3) perforin (since Th1-type
CD4+ T cells, as well as CD8+ T cells and NK
cells, have been reported to utilize this effector molecule
[20]) and Fas ligand (FasL), which is required for the
susceptibility of cells to Fas-mediated cytolysis. Other mice examined
were deficient in the receptor for IFN-
or inducible nitric oxide
synthase (iNOS), which is reported to be an IFN-
-inducible effector
against pathogens that adopt intracellular niches such as the
phagolysosome utilized by Eimeria.
IFN-

/
mice were consistently up to 10-fold more
susceptible to infection than congenic C57BL/6 mice and, like
I-A
/
mice, shed for a longer patent period (Table
2,
experiment 1).
Similar results were obtained with IFN-

receptor
/
(IFN-

R
/
) mice (Fig.
2). By contrast, the primary response was
insensitive
to IL-4 deficiency (Table
2, experiment 2), whereas IL-6
deficiency
produced reproducible increases, albeit small, in oocyst
output
but no increase in patent period (Table
2, experiment 3).
Although
the difference was small, the internal controls were
sufficiently
rigorous that statistical significance could be easily
assigned
(
P < 0.05). Conversely, primary responses
were insensitive to
mutations in perforin, FasL, and iNOS (Table
3 and
Fig.
2). Integration
of the data in Tables
1 to
3 with previously
published work
supports the hypothesis that MHC class II-restricted,
IFN-

-producing
CD4
+ cells are important in the
anti-
Eimeria response but it adds
a role for cells
responsive to
2m-associated molecules and defines
a contribution of IL-6. The insensitivity to either perforin or
FasL deficiency supports the findings that neither CD8
+
cytolytic T cells nor NK cells are required for immunity against
this
parasite (
49). Moreover, the data in Fig.
2 demonstrate
that
although the primary response depends on IFN-

and its receptor,
this
dependency does not reflect any requirement for iNOS.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
IFN R / mice but not
iNOS / mice are more highly susceptible than C57BL/6
mice to primary infection with E. vermiformis. Mice were
infected with 1,000 sporulated oocysts of E. vermiformis.
Results of oocyst counts and patent periods are means ± standard
errors from groups of 6 to 10 individually housed animals. *,
significant difference between experimental groups infected at the same
time (P < 0.05).
|
|
Requirements for the secondary response to Eimeria.
Many
of the mice studied in Tables 1 to 3 were subsequently rechallenged, so
that the requirements for the secondary response could be compared to
the requirements for the primary response. In each case, a simultaneous
primary infection of syngeneic mice was undertaken to control for the
reproductive index of the inoculum used. Not surprisingly, complete
immunity was evident in TAP1
/
(Table 1),
IL-4
/
(Table 2), perforin
/
, FasL mutant
(Table 3), and iNOS
/
mice (data not shown) in which
strong primary responses developed. Likewise, the slightly reduced
primary response of IL-6
/
mice was followed by a robust
secondary response (Table 2). However, at variance with the primary
infection data was the complete immunity to rechallenge of
2m
/
mice and IFN-
/
mice (Tables 1 and 2). Likewise, I-A
/
mice, which are
an order of magnitude more susceptible to primary infection, showed an
almost 20-fold increase in resistance to rechallenge (Table 1). It
cannot be argued that the secondary response is insensitive to any
mutation, since 
-T-cell deficient mice are highly susceptible to
primary and secondary infections, with no decrease in oocyst output at
secondary infection compared with that at primary infection (Fig. 1).
Adoptive transfer of the secondary response to Eimeria
from mutant mice.
The development of immunity to E. vermiformis can be demonstrated by adoptive transfer of mesenteric
lymph node cells (MLNC) to irradiated naive recipients (38,
42) or T-cell-deficient recipients (A. L. Smith and A. C. Hayday, unpublished data) (see below). Although complete protection
is rarely achieved, naive recipients of MLNC from mice 8 to 12 days
after primary infection are invariably more resistant to infection than
mice inoculated with cells from naive mice or mice mock inoculated with
PBS (38; A. L. Smith and A. C. Hayday,
unpublished observations). Therefore, this well-established approach
was used to test whether the relative resistance to secondary infection
in I-A
/
mice reflects the development of true,
transferable, cell-mediated immunity.
T-cell-deficient TCR(

×

)
/
mice were used
as recipients, as they are highly susceptible to infection (A. L. Smith and A.
C. Hayday, submitted for publication) and do not
require irradiation
prior to transfer, a particular concern with
intestinal epithelium-tropic
pathogens since the epithelium itself is
sensitive to irradiation.
The data collected into groups in Fig.
3 are derived from a single
large
experiment in which all mice were infected and analyzed
in parallel.
The data are fully representative of other experiments
in which
smaller component groups of the experiment were examined
(data not
shown).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
MHC class II / mice develop transferable
immunity to E. vermiformis that functions in MHC class
II+ recipients. The recipient mice listed were infected
with 1,000 sporulated oocysts of E. vermiformis 24 h
after receiving inocula listed (3dpsi, cells harvested on the third day
following secondary infection). Oocyst counts are means ± standard errors from groups of 6 to 10 individually housed animals.
|
|
The mice of group 1 showed that TCR(

×

)
/
mice mock inoculated with PBS were over 1 order of magnitude more
susceptible than
congenic C57BL/6 mice mock inoculated with PBS in the
same experiment
(Fig.
3). In fact, TCR(

×

)
/
mice, unlike any other strains, would
occasionally die because
of overwhelming infection (the uniquely high
susceptibility of
these mice is the focus of a separate study [A.
L. Smith and A.
C. Hayday, submitted]). Similarly,
TCR(

×

)
/
mice that received cells from
naive I-A
/
mice were also approximately 1 order of
magnitude more susceptible
than C57BL/6 controls (Fig.
3) and were not
significantly different
in their susceptibility from unmanipulated
TCR(

×

)
/
mice. By contrast, adoptive
transfer of T cells from naive but
immunocompetent C57BL/6 mice
measurably reduced the susceptiblity
of TCR(

×

)
/
mice (note that resistance in adoptive-transfer
recipients is
never as great as in infected, unmanipulated donors
[Fig.
3] [
42]).
These differences in the capacities
of cells from naive I-A
/
mice and naive C57BL/6 mice to
confer protection parallel the
high susceptibility of naive
I-A
/
mice to primary infection (Table
1).
Nonetheless, these differences largely disappear when donor cells are
derived from previously-infected I-A
/
or C57BL/6 mice
(Table
4). Relative to cells from naive
C57BL/6
mice, cells taken either from mice at the peak of primary
infection
or from mice 3 days after secondary infection both show
increased
capacity to confer protection (Fig.
3; A. L. Smith and
A. C. Hayday,
unpublished). Strikingly, a comparable capacity was
shown by cells
harvested from I-A
/
mice (Table
4). This
indicates that the dramatically improved
resistance of
I-A
/
mice to secondary, as opposed to primary,
challenge is manifest
in transferable immunity. Importantly, the
effectors which develop
in the infected I-A
/
mice
function in an I-A-intact mouse, indicating that they are
not specific
to atypical antigen presentation pathways that may
be up-regulated in
MHC class II
/
mice.
 |
DISCUSSION |
The results in this paper are from a large number of internally
controlled experiments aimed at clarifying how an animal mounts an
immune response to a natural infection of its gut epithelium. The
infection system under study, coccidiosis, is a protozoan-induced disease that afflicts most vertebrates before and throughout breeding age and as such may have provided an evolutionary pressure on intestinal immune responses. In addition to being economically important in its own right, Eimeria is closely related to
several human pathogens that either reside in or enter the body via the intestinal epithelium, e.g., Cryptosporidium parvum and
T. gondii.
The data presented support the previously published hypothesis that the
immune response to primary infection is dominated by MHC class
II-restricted CD4+, IFN-
-producing 
T cells; for
example, IFN-
/
and I-A
/
mice are as
susceptible as TCR
/
mice. In any studies of knockout
mice, important physiological mediators can fail to score as essential
because of functional redundancy. This may be the case for class II MHC
and IFN-
in the secondary response. Nonetheless, neither of these
components can be substituted for in the primary response. Thus, one
can conclude that the primary infection is most likely characterized by
a dominant Th1-type response, while the secondary response can be both
primed and executed in the absence of class II MHC or IFN-
.
Evidence that cells other than MHC class II-restricted T cells are
activated during the primary response is provided in this study by data
that the primary response is also sensitive to
2m deficiency and influenced, albeit weakly, by IL-6 deficiency (Table 1).
This seems to parallel other instances in which more than one class of
antigen-presenting molecule is important for the establishment of the
full T-cell response (57). Future studies will determine
whether the cells sensitive to
2m deficiency recognize antigens presented by classical class Ia MHC, but in a TAP-independent fashion, or TAP1-independent, class I-related molecules, of which there
are a growing number of candidates, e.g., CD1, TL, RAE, H60, and any
putative murine homolog of MICA/B that is expressed on activated human
enterocytes (9, 16, 29, 45, 48, 50).
There is precedent for the involvement of T cells reactive to such
antigens in the response to protozoal infection. Thus, murine T-cell
types including TCR
CD4+ NK1.1 cells have been shown
to be CD1 restricted (23), and antibody synthesis supported
by such cells was reported following infection by
Plasmodium, another apicomplexan (44). One of the characteristics of such cells is an oligoclonal TCR repertoire, most
utilizing V
14J
281 and a limited set of V
s. Intriguingly, one
such set of cells expressing V
3 has been documented exclusively in
the intestine (25). Although CD1-restricted,
CD4+ NK1.1+ cells are notable for their
capacity to produce IL-4 within 30 min of anti-CD3 treatment
(58), they can also produce IL-2 and IFN-
(3,
13). Hence the sensitivity of the antieimerian response to
2m deficiency but not to IL-4 deficiency does not preclude a role for TCR
CD4+ NK1.1 cells.
Interestingly,
2m deficiency has been reported to reduce
the number of IFN-
-producing intestinal intraepithelial lymphocytes
in response to intestinal L. monocytogenes infection (15).
The rapidity and effectiveness of the secondary response to
Eimeria are both extremely high and represent hoped-for
standards for oral vaccines for a plethora of infectious diseases.
Moreover, antieimerian immunity is long-lived, in contrast to the
commonly cited transient status of memory for mucosal pathogens
(reviewed in reference 2). Nonetheless, it had previously been inferred from antibody depletion studies that the requirements for the secondary
response might be less than those for the primary response. For
example, both anti-CD4 and anti-IFN-
antibodies administered in vivo
inhibited the primary but not the secondary response (38, 40,
41). Heretofore, the interpretation of such studies had to be
qualified by the uncertain capacity of administered antibodies to
penetrate the GALT, where memory cells might reside. Such
qualifications are offset by the current experiments that show that a
memory response, either 100% complete or 95 to 99% complete, clearly develops in IFN-
/
and MHC class II
/
mice, respectively, even though these mice cannot develop primary responses of any magnitude. These data are quite different from those
on the effects of 
-T-cell deficiency that obliterates both the
primary and secondary responses equally (Fig. 1) (33). Moreover, we show that the increased resistance of I-A
/
mice is reflected in genuine transferable immunity (Table
4). Such memory is not provided by 
T cells or B cells (A. L. Smith and A. C. Hayday, submitted
and unpublished studies), and it will be interesting to determine the
nature of the cells that mediate such immunity.
The complete dependence of the memory response on 
T cells (Fig.
1) means that in the
2m
/
mice and
IA
/
mice the memory response is most likely driven by
different T-cell populations: those selected on
2m-associated MHC in IA
/
mice or those
selected on class II MHC in
2m
/
mice.
One might hypothesize that a variety of different memory cells can be
primed during the initial encounter with an antigen. Possibly these
cells compete with each other for long-term survival and reactivation.
This would be consistent with the demonstration that B cells compete
with each other for a limited number of available niches during
recirculation (11). It would also seem consistent with the
concept that Th1 and Th2 dichotomies reflect population effects rather
than the exclusive and precise commitment of every cell clone to one
particular phenotype (21). Hence, in the absence of one
population (e.g., IFN-
-producing, MHC class II-resticted CD4+ 
T cells) other antigen-experienced cell types
may develop more successfully and subsequently act to provide memory.
The factors that prevent similar functional redundancy in the primary response need to be clarified, but, until proven otherwise, it may
simply be the time constraint in making a response de novo to a rapidly
proliferating pathogen. This could likewise explain the capacity to
"see" fully effective recall responses in mice, such as the
IFN-
/
strain, in which there was no measurable
primary response.
The capacity to elicit pathogen-limiting memory responses in the
absence of all molecules except for TCR
may be germane to vaccine
programs that would be designed to recapitulate the efficacy of the
anti-Eimeria response. Different adjuvants and vaccine
delivery regimens are known to promote some effector functions better
than others. The findings presented here suggest, perhaps surprisingly,
that there may be room for some latitude in vaccine design. So long as
appropriate, neutralizing epitopes can be presented and recognized,
effective immunoprotective T cells may develop in multiple compartments.
 |
ACKNOWLEDGMENTS |
The work was supported by NIH grants AI 27855 and AI 38932 to
A.H., by the Wellcome Trust (A.H.), and by the BBSRC (A.L.S). Laboratory facilities were supported by the Dunhill Medical Trust.
We thank Bob Tigelaar, Scott Roberts, Jasmine Sia, Craig Findly,
Elizabeth Ramsburg, and other colleagues for their valuable input
during this study.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: The Peter
Gorer Department of Immunobiology, Guy's, King's and St
Thomas' Medical School, King's College London, 3rd Floor New Guy's
House, Guy's Hospital, London, SE1 9RT, United Kingdom. Phone: 44 020 7955 4355. Fax: 44020 7955 4961. E-mail:
adrian.hayday{at}kcl.ac.uk.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Abbas, A. K.,
K. M. Murphy, and A. Sher.
1996.
Functional diversity of helper T lymphocytes.
Nature (London)
383:787-793[CrossRef][Medline].
|
| 2.
|
Ahmed, R., and D. Gray.
1996.
Immunological memory and protective immunity: understanding their relation.
Science
272:54-60[Abstract].
|
| 3.
|
Arase, H.,
N. Arase, and T. Saito.
1996.
Interferon production by natural killer (NK) cells and NK1.1+ T cells upon NKRP1 crosslinking.
J. Exp. Med.
183:2391-2396[Abstract/Free Full Text].
|
| 4.
|
Beaman, M. H.,
S. Y. Wong, and J. S. Remington.
1992.
Cytokines, toxoplasma and intracellular parasitism.
Immunol. Rev.
127:97-117[CrossRef][Medline].
|
| 5.
|
Bix, M., and D. Raulet.
1992.
Inefficient positive selection of T cells directed by haematopoietic cells.
Nature (London)
359:330-333[CrossRef][Medline].
|
| 6.
|
Cheroute, H.,
H. R. Holcombe,
S. Tangri,
A. R. Castano,
M. Teitell,
J. E. W. Miller,
S. Cardell,
C. Benoist,
D. Mathis,
W. D. Huse,
P. A. Peterson, and M. Kronenburg.
1995.
Antigen presenting function of the TL antigen and mouse CD1 molecules.
Immunol. Rev.
147:31-51[CrossRef][Medline].
|
| 7.
|
Cosgrove, D.,
D. Gray,
A. Dierich,
J. Kaufman,
M. Lemeur,
C. Benoist, and D. Mathis.
1991.
Mice lacking MHC class II molecules.
Cell
66:1051-1066[CrossRef][Medline].
|
| 8.
|
Cox, F. E. G., and F. Y. Liew.
1992.
T cell subsets and cytokines in parasitic infections.
Immunol. Today
13:445-448[CrossRef][Medline].
|
| 9.
|
Crowley, M. P.,
Z. Reich,
N. Mavaddat,
J. D. Altman, and Y.-H. Chien.
1997.
The recognition of the non-classical major histocompatibility complex (MHC) class I molecule, T10, by the  T cell, G8.
J. Exp. Med.
185:1223-1230[Abstract/Free Full Text].
|
| 10.
|
Current, W. L.,
S. J. Upton, and P. L. Long.
1990.
Taxonomy and life cycles, p. 1-16.
In
P. L. Long (ed.), Coccidiosis of man and domestic animals. CRC Press, Boca Raton, Fla.
|
| 11.
|
Cyster, J.,
S. Hartley, and C. Goodnow.
1994.
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire.
Nature
371:389-395[CrossRef][Medline].
|
| 12.
|
Dalrymple, S. A.,
L. A. Lucian,
R. Slattery,
T. McNiel,
D. M. Aud,
S. Fuchino,
F. Lee, and R. Murray.
1995.
Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia.
Infect. Immun.
63:2262-2268[Abstract].
|
| 13.
|
Denkers, E. Y.,
T. Scharton-Kirsten,
S. Barbieri,
P. Caspar, and A. Sher.
1996.
A role for CD4+NK1.1+ T lymphocytes as major histocompatibility complex class II-independent helper cells in the generation of CD8+ effector function against intracellular infection.
J. Exp. Med.
184:131-139[Abstract/Free Full Text].
|
| 14.
|
Eichelberger, M.,
A. McMickle,
M. Blackman,
P. Mombaerts,
S. Tonegawa, and P. C. Doherty.
1995.
Functional analysis of the TCR alpha beta+ cells that accumulate in the pneumonic lung of influenza virus-infected TCR-alpha / mice.
J. Immunol.
154:1569-1576[Abstract].
|
| 15.
|
Emoto, M.,
O. Neuhaus,
Y. Emoto, and S. H. E. Kaufmann.
1996.
Influence of 2-microglobulin expression on gamma interferon secretion and target cell lysis by intraepithelial lymphocytes during intestinal Listeria monocytogenes infection.
Infect. Immun.
64:569-575[Abstract].
|
| 16.
|
Exley, M.,
J. Garcia,
S. P. Balk, and S. Porcelli.
1997.
Requirements for CD1d recognition by human invariant V 24+CD4-CD8-T cells.
J. Exp. Med.
186:109-120[Abstract/Free Full Text].
|
| 17.
|
Findly, R. C.,
S. J. Roberts, and A. C. Hayday.
1993.
Dynamic response of murine gut intraepithelial T cells after infection by the coccidian parasite Eimeria.
Eur. J. Immunol.
23:2557-2564[Medline].
|
| 18.
|
Fu, Y.-X.,
C. E. Roark,
K. Kelly,
D. Drevets,
P. Campbell,
R. O'Brien, and W. Born.
1994.
Immune protection and control of inflammatory tissue necrosis by gamma delta T cells.
J. Immunol.
150:550-555[Abstract].
|
| 19.
|
Grusby, M. J.,
R. S. Johnson,
V. E. Papaioannou, and L. H. Glimcher.
1991.
Depletion of CD4(+) T cells in major histocompatibility complex II-deficient mice.
Science
253:1417-1420[Abstract/Free Full Text].
|
| 20.
|
Hahn, S.,
R. Gehri, and P. Erb.
1995.
Mechanism and biological significance of CD4-mediated cytotoxicity.
Immunol. Rev.
146:56-79.
|
| 21.
|
Kelso, A.
1995.
Th1 and Th2 subsets: paradigms lost?
Immunol. Today
16:374-379[CrossRef][Medline].
|
| 22.
|
Ladel, C. H.,
C. Blum,
K. Dreher,
K. Reifenburg, and S. H. E. Kaufmann.
1995.
Protective role of  T cells and  T cells in tuberculosis.
Eur. J. Immunol.
25:2877-2881[Medline].
|
| 23.
|
Lantz, O., and A. Bendelac.
1994.
An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.
J. Exp. Med.
180:1097-1106[Abstract/Free Full Text].
|
| 24.
|
Locksley, R. M., and J. A. Louis.
1992.
Immunology of leishmaniasis.
Curr. Opin. Immunol.
4:413-418[Medline].
|
| 25.
|
Masuda, K.,
Y. Makino,
J. Cui,
T. Ito,
T. Tokuhisa,
Y. Takahama,
H. Koseki,
K. Tsuchida,
T. Koike,
H. Moriya,
M. Amano, and M. Taniguchi.
1997.
Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells.
J. Immunol.
158:2076-2082[Abstract].
|
| 26.
|
Mombaerts, P.,
J. Arnoldi,
F. Russ,
S. Tonogawa, and S. H. E. Kaufmann.
1993.
Different roles of  and  T cells in immunity against an intracellular bacterial pathogen.
Nature (London)
365:53-56[CrossRef][Medline].
|
| 27.
|
Mosmann, T. R., and R. L. Coffman.
1989.
Heterogeneity of cytokine secretion patterns and function of helper T cells.
Adv. Immunol.
46:111-147[Medline].
|
| 28.
|
Mukasa, A.,
K. Hiromatsu,
G. Matsuzaki,
R. O'Brien,
W. Born, and K. Nomoto.
1995.
Bacterial infection of the testis leading to autoagressive immunity triggers apparently opposed responses of alpha beta and gamma delta T cells.
J. Immunol.
155:2047-2056[Abstract].
|
| 29.
|
Panga, A.,
A. Barone, and L. Mayer.
1994.
Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of non-classical restriction elements.
J. Exp. Med.
179:943-950[Abstract/Free Full Text].
|
| 30.
|
Pao, W.,
L. Wen,
A. L. Smith,
A. Gulbranson-Judge,
B. Zheng,
G. Kelsoe,
M. J. Owen,
I. MacLennan, and A. C. Hayday.
1996.
 T cell help of B cells is induced by repeated parasitic infection, in the absence of other T cells.
Curr. Biol.
6:1317-1325[CrossRef][Medline].
|
| 31.
|
Peng, S.,
M. P. Madaio,
A. C. Hayday, and J. Craft.
1996.
Propagation and regulation of autoimmunity by  T cells.
J. Immunol.
157:5689-5698[Abstract].
|
| 32.
|
Rincon, M.,
J. Anguita,
T. Nakamura,
E. Fikrig, and R. A. Flavell.
1997.
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells.
J. Exp. Med.
185:461-469[Abstract/Free Full Text].
|
| 33.
|
Roberts, S. J.,
A. L. Smith,
A. B. West,
L. Wen,
R. C. Findly,
M. J. Owen, and A. C. Hayday.
1996.
T cell  + and  + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium.
Proc. Natl. Acad. Sci. USA
93:11774-11779[Abstract/Free Full Text].
|
| 34.
|
Romani, L.,
A. Mencacci,
E. Cenci,
R. Spaccapello,
C. Toniatti,
P. Puccetti,
F. Bistoni, and V. Poli.
1996.
Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin-6 deficient mice infected with Candida albicans.
J. Exp. Med.
183:1345-13555[Abstract/Free Full Text].
|
| 35.
|
Rose, M. E.
1987.
Eimeria, isospora and cryptosporidium, p. 275-312.
In
E. J. L. Soulsby (ed.), Immunology, immunopathology and immunoprophylaxis of parasitic infections, vol. 3. CRC Press, Boca Raton, Fla.
|
| 36.
|
Rose, M. E., and P. Hesketh.
1986.
Eimerian life cycles: the patency of Eimeria vermiformis, but not Eimeria pragensis is subject to host (Mus musculus) influence.
J. Parasitol.
72:949-952[CrossRef][Medline].
|
| 37.
|
Rose, M. E.,
P. Hesketh, and D. Wakelin.
1992.
Immune control of murine coccidiosis: CD4+ and CD8+ lymphocytes contribute differentially in resistance to primary and secondary infections.
Parasitology
105:349-354.
|
| 38.
|
Rose, M. E.,
H. S. Joysey,
P. Hesketh,
R. K. Grencis, and D. Wakelin.
1988.
Mediation of immunity to Eimeria vermiformis in mice by L3T4+ T cells.
Infect. Immun.
56:1760-1765[Abstract/Free Full Text].
|
| 39.
|
Rose, M. E.,
D. G. Owen, and P. Hesketh.
1984.
Susceptibility to coccidiosis: effect of strain of mouse on reproduction of Eimeria vermiformis.
Parasitology
88:45-54.
|
| 40.
|
Rose, M. E.,
D. Wakelin, and P. Hesketh.
1989.
Gamma interferon controls Eimeria vermiformis primary infection in BALB/c mice.
Infect. Immnun.
57:1599-1603[Abstract/Free Full Text].
|
| 41.
|
Rose, M. E.,
D. Wakelin, and P. Hesketh.
1991.
Interferon-gamma-mediated effects upon immunity to coccidial infections in the mouse.
Parasite Immunol.
13:63-74[Medline].
|
| 42.
|
Rose, M. E.,
D. Wakelin,
H. S. Joysey, and P. Hesketh.
1988.
Immunity to coccidiosis: adoptive transfer in NIH mice challenged with Eimeria vermiformis.
Parasite Immunol.
10:59-69[Medline].
|
| 43.
|
Ruzek, M. C.,
A. H. Miller,
S. M. Opal,
B. D. Pearce, and C. A. Biron.
1997.
Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection.
J. Exp. Med.
185:1185-1192[Abstract/Free Full Text].
|
| 44.
|
Schofield, L.,
M. J. McConville,
D. Hansen,
A. S. Campbell,
B. Fraser-Reid,
M. J. Grusby, and S. D. Tachado.
1999.
CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NK T cells.
Science
283:225-229[Abstract/Free Full Text].
|
| 45.
|
Shawar, S. M.,
J. M. Vyas,
J. R. Rodgers, and R. R. Rich.
1994.
Antigen presentation by major histocompatibity complex class Ib molecules.
Annu. Rev. Immunol.
12:839-880[CrossRef][Medline].
|
| 46.
|
Shiohara, T.,
N. Moriya,
J. Hayakawa,
S. Itohara, and H. Ishikawa.
1996.
Resistance to cutaneous graft-vs.-host disease is not induced in T cell receptor delta gene-mutant mice.
J. Exp. Med.
183:1483-1489[Abstract/Free Full Text].
|
| 47.
|
Shirley, M. W.
1992.
Research on avian coccidia: an update.
Br. Vet. J.
148:479-499[Medline].
|
| 48.
|
Sieling, P. A.,
D. Chatterjee,
S. A. Porcelli,
T. I. Prigozy,
R. J. Mazzaccaro,
T. Soriano,
B. R. Bloom,
M. B. Brenner,
M. Kronenberg,
P. J. Brennan, and R. L. Modlin.
1995.
CD1-restricted T cell recognition of microbial lipoglycan antigens.
Science
269:227-230[Abstract/Free Full Text].
|
| 49.
|
Smith, A. L.,
M. E. Rose, and D. Wakelin.
1994.
The role of natural killer cells in resistance to coccidiosis; investigations in a murine model.
Clin. Exp. Immunol.
97:273-279[Medline].
|
| 50.
|
Sugita, M.,
R. M. Jackman,
E. van Donselaar,
S. M. Behar,
R. A. Rogers,
P. J. Peters,
M. B. Brenner, and S. A. Porcelli.
1996.
Cytoplasmic tail-dependent localization of CD1b antigen presenting molecules to MIIC's.
Science
273:349-352[Abstract].
|
| 51.
|
Szczepnik, M.,
L. R. Anderson,
H. Ushio,
W. Ptak,
M. J. Owen,
A. C. Hayday, and P. W. Askenase.
1996.
Gamma delta T cells from tolerized alpha beta T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their inteferon-gamma production in vitro.
J. Exp. Med.
184:2129-2139[Abstract/Free Full Text].
|
| 52.
|
Tsuji, M.,
P. Mombaerts,
L. Lefrancois,
R. S. Nussensweig,
F. Zavala, and S. Tonegawa.
1994.
 T cells contribute to immunity against the liver stages of malaria in  T-cell-deficient mice.
Proc. Natl. Acad. Sci. USA
91:345-349[Abstract/Free Full Text].
|
| 53.
|
Van-Kaer, L.,
P. G. Ashton-Rickardt,
H. L. Ploegh, and S. Tonegawa.
1992.
TAP1 mutant mice are deficient in antigen presentation, surface class I molecules and CD4-8+ T cells.
Cell
71:1205-1214[CrossRef][Medline].
|
| 54.
|
Wakelin, D., and M. E. Rose.
1990.
Immunity to coccidiosis, p. 281-306.
In
P. L. Long (ed.), Coccidiosis of man and domestic animals. CRC Press, Boca Raton, Fla.
|
| 55.
|
Weiner, H. L.
1997.
Oral tolerance for the treatment of autoimmune diseases.
Annu. Rev. Med.
48:341-351[CrossRef][Medline].
|
| 56.
|
Weir, D. M.
1986.
Handbook of experimental immunology, 4th ed., vol. II.
Blackwell Scientific Publications, Oxford, United Kingdom.
|
| 57.
|
Wicker, L. S.,
E. H. Leiter,
J. A. Todd,
R. J. Renjilian,
E. Peterson,
P. L. Fischer,
M. Zijlstra,
R. Jaenisch, and L. B. Peterson.
1994.
Beta 2 microglobulin deficient NOD mice do not develop insulin dependent diabetes.
Diabetes
43:500-504[Abstract].
|
| 58.
|
Yoshimoto, T., and W. Paul.
1994.
CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.
J. Exp. Med.
174:1285.
|
| 59.
|
Zijlstra, M.,
M. Bix,
N. E. Simister,
J. M. Loring,
D. H. Raulet, and R. Jaenisch.
1990.
2-Microglobulin deficient mice lack CD4( )CD8(+) cytolytic T cells.
Nature (London)
344:742-746[CrossRef][Medline].
|
Infection and Immunity, November 2000, p. 6273-6280, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Inagaki-Ohara, K., Dewi, F. N., Hisaeda, H., Smith, A. L., Jimi, F., Miyahira, M., Abdel-Aleem, A. S. F., Horii, Y., Nawa, Y.
(2006). Intestinal Intraepithelial Lymphocytes Sustain the Epithelial Barrier Function against Eimeria vermiformis Infection. Infect. Immun.
74: 5292-5301
[Abstract]
[Full Text]
-
Kwa, S.-f., Beverley, P., Smith, A. L.
(2006). Peyer's Patches Are Required for the Induction of Rapid Th1 Responses in the Gut and Mesenteric Lymph Nodes during an Enteric Infection.. J. Immunol.
176: 7533-7541
[Abstract]
[Full Text]
-
Rothwell, L., Young, J. R., Zoorob, R., Whittaker, C. A., Hesketh, P., Archer, A., Smith, A. L., Kaiser, P.
(2004). Cloning and Characterization of Chicken IL-10 and Its Role in the Immune Response to Eimeria maxima. J. Immunol.
173: 2675-2682
[Abstract]
[Full Text]
-
Ramsburg, E., Tigelaar, R., Craft, J., Hayday, A.
(2003). Age-dependent Requirement for {gamma}{delta} T Cells in the Primary but Not Secondary Protective Immune Response against an Intestinal Parasite. JEM
198: 1403-1414
[Abstract]
[Full Text]
-
Smith, A. L., Hesketh, P., Archer, A., Shirley, M. W.
(2002). Antigenic Diversity in Eimeria maxima and the Influence of Host Genetics and Immunization Schedule on Cross-Protective Immunity. Infect. Immun.
70: 2472-2479
[Abstract]
[Full Text]